Trinity Biotech | TRIB - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Bayer EUR -1.16B 735M 2025-09
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
EDAP TMS EUR -4.91M 597K 2025-09
J&J USD 7.82B 2.86B 2026-03
Mesa Laboratories USD -2.22M 6.03M 2024-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Plus Therapeutics USD -5.71M 1.29M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Siemens EUR 2.39B 505M 2025-09
Surmodics USD -5.9M 1.61M 2025-06
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tosoh JPY 30.93B 18.15B 2025-12
Trinity Biotech USD -5.06M 10.74M 2025-09
Veracyte USD 29.97M 10.66M 2026-03